Stroke Revisited: Dyslipidemia in Stroke, 1st ed. 2021
Stroke Revisited Series

Coordinators: Lee Seung-Hoon, Kang Min Kyoung

Language: English
Cover of the book Stroke Revisited: Dyslipidemia in Stroke

Subject for Stroke Revisited: Dyslipidemia in Stroke

105.49 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Stroke Revisited: Dyslipidemia in Stroke
Publication date:
219 p. · 17.8x25.4 cm · Paperback

147.69 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Stroke Revisited: Dyslipidemia in Stroke
Publication date:
Support: Print on demand
This book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.
Part I. Basic Science: Dyslipidemia and Stroke

1. Role of Dyslipidemia in Atherosclerosis

2. Effects of Dyslipidemia on the Cerebral vessels

Part II. Clinical Significance of Dyslipidemia in Stroke

3. Impact of Dyslipidemia on Ischemic Stroke

4. Dyslipidemia and Hemorrhagic Stroke

5. Clinical biomarkers of Dyslipidemia

Part III. Treatment of Dyslipidemia in Stroke Patients

6. Therapeutic Lifestyle Modification

7. Statins

8. Ezetimibe

9. Fibrate and Niacin

10. Fish Oils

11. PCSK9 inhibiting monoclonal antibodies

12. PCSK9 inhibiting siRNA

13. Understanding of Clinical Practice Guidelines for Dyslipidemia

Part Ⅳ. Management of Dyslipidemia in Clinical Practice of Stroke

14. Practical Management of Dyslipidemia in Stroke Patients

15. Practical Dyslipidemia Management in Stroke-specific Situations

16. Dyslipidemia in Women: Etiology and Management

17. Safety Considerations of Pharmacological Treatment

Seung-Hoon Lee, MD
Professor, Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea
Chairman, Korean Cerebrovascular Research Institute, Republic of Korea

Min Kyoung Kang, MD

Department of Neurology, Uijeongbu Eulji Medical Center

Gyeonggi, Republic of Korea


Presents state of the art knowledge

Covers both basic and clinical aspects in detail

Evaluates currently available treatment modalities

Discusses a range of specific considerations

Provides clear management guidance